FDA mulls expanded universe of nonprescription drugs.

Detalles Bibliográficos
Publicado en:American Journal of Health-System Pharmacy Vol. 69; no. 9; pp. 734 - 736
Autor principal: Traynor, Kate
Formato: Journal Article
Publicado: Oxford University Press / USA 5/1/2012
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104556440&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 104556440
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10792082
        1X3
      jtl: American Journal of Health-System Pharmacy
      issn: 10792082
      maglogo: N
    pubinfo:
      dt: 5/1/2012
      vid: 69
      iid: 9
      pid: 622
      pub: Oxford University Press / USA
    artinfo:
      ui:
        104556440
        2011528376
        10.2146/news120031
        NLM22517017
        104556440
      ppf: 734
      ppct: 2
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: FDA mulls expanded universe of nonprescription drugs.
      aug:
        au: Traynor, Kate
      sug:
        subj:
          Drugs, Non-Prescription
          Pharmacist Attitudes
          Patient Safety
          United States Food and Drug Administration
          Reimbursement Mechanisms
          Risk Assessment
          Government Regulations
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N